Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre.
about
Revolutionizing Alzheimer's disease and clinical trials through biomarkersNeuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's diseaseAlzheimer's disease--subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studiesVascular aspects of cognitive impairment and dementiaThe pericyte: a forgotten cell type with important implications for Alzheimer's disease?Therapeutic and diagnostic challenges for frontotemporal dementiaThe pathobiology of vascular dementiaInsight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profilingImpaired Aβ clearance: a potential link between atherosclerosis and Alzheimer's diseaseCerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's diseasePathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesisThe link between cardiovascular risk, Alzheimer's disease, and mild cognitive impairment: support from recent functional neuroimaging studies.Contributions and complexities from the use of in vivo animal models to improve understanding of human neuroimaging signals.The Gothenburg MCI study: Design and distribution of Alzheimer's disease and subcortical vascular disease diagnoses from baseline to 6-year follow-upMatrix Metalloproteinase-Mediated Neuroinflammation in Vascular Cognitive Impairment of the Binswanger TypeStroke, Vascular Dementia, and Alzheimer's Disease: Molecular Links.The effectiveness and unique contribution of neuropsychological tests and the δ latent phenotype in the differential diagnosis of dementia in the uniform data set.Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition.Association between risk factors for vascular dementia and adiponectin.Older Adults Taking AT1-Receptor Blockers Exhibit Reduced Cerebral Amyloid Retention.Social Cognition Deficits: Current Position and Future Directions for Neuropsychological Interventions in Cerebrovascular Disease.Back to the future with phenotypic screeningModeling the Relationships Among Late-Life Body Mass Index, Cerebrovascular Disease, and Alzheimer's Disease Neuropathology in an Autopsy Sample of 1,421 Subjects from the National Alzheimer's Coordinating Center Data SetDiagnostic criteria for vascular cognitive disorders: a VASCOG statement.New therapeutic approaches for Alzheimer's disease and cerebral amyloid angiopathy.Treatment of vascular risk factors in patients with a diagnosis of Alzheimer's disease: a systematic review.The overlap between vascular disease and Alzheimer's disease--lessons from pathology.White matter hyperintensities and imaging patterns of brain ageing in the general population.Advanced brain aging: relationship with epidemiologic and genetic risk factors, and overlap with Alzheimer disease atrophy patterns.The key role of transient receptor potential melastatin-2 channels in amyloid-β-induced neurovascular dysfunction.Aggregate effects of vascular risk factors on cerebrovascular changes in autopsy-confirmed Alzheimer's diseaseContemplating Alzheimer's disease and the contribution of white matter hyperintensities.Cognitive health begins at conception: addressing dementia as a lifelong and preventable conditionCilostazol add-on therapy in patients with mild dementia receiving donepezil: a retrospective studyEffects of traumatic brain injury and posttraumatic stress disorder on Alzheimer's disease in veterans, using the Alzheimer's Disease Neuroimaging Initiative.Diabetes Mellitus, Cognitive Impairment, and Traditional Chinese Medicine.Pulse pressure in relation to tau-mediated neurodegeneration, cerebral amyloidosis, and progression to dementia in very old adultsApolipoprotein E-dependent load of white matter hyperintensities in Alzheimer's disease: a voxel-based lesion mapping studySystems Pharmacology Dissecting Holistic Medicine for Treatment of Complex Diseases: An Example Using Cardiocerebrovascular Diseases Treated by TCMThe transitional association between β-amyloid pathology and regional brain atrophy
P2860
Q26744882-531BD3DD-DB42-4DD2-89A4-B23AED315D2BQ26750515-7061B3D5-58E2-422F-B425-1D96FCEA9A73Q26798325-3D83F03A-5D1D-4410-B6CF-28CCD4261D1AQ26820823-0D29EB41-00A1-4563-B105-3221E97B4162Q26852369-116B1657-5EB1-4E2E-9947-C726304C2192Q26998919-654A161A-983D-4078-B02F-D89AF698C62AQ27006033-5E621B6E-F21C-44E0-B641-41F0E07685F9Q28076999-07576E3B-6E46-4B40-BE3B-9A4469C061C1Q28082612-F5CC051A-74EA-4C70-B25A-CB673B059A66Q28087176-2195D8EA-4A31-45A0-8445-9B7F01B41147Q30235369-18FCE2A8-DB46-4C6A-B087-B41BA8A4C293Q30830414-F02DBB78-E0E3-49D6-94EE-CB84B3B977B4Q30847706-F77D44AE-AFA3-4504-A5EC-A7AB6F9FF43AQ30980369-48697E90-BD6F-414F-A6CA-E7FC79DD2F2DQ31060741-7183792D-2603-4C88-A805-5809FFEDA06CQ31124464-82A629EC-069B-4F30-B817-642185E93319Q31140102-2D042E10-C4C2-419B-B5D9-A43055D85F7DQ33559175-EAC4DC6E-66CC-4CDE-8261-16581797865AQ33594133-077AE8CA-623C-415E-AE6F-77827EF73D9BQ33822159-8429D618-46CD-4A10-9063-E159EFC8C228Q33907409-C20545DA-B476-4292-BBB1-8F3DB5545B1DQ33918218-973E0D4B-FA33-4862-BDF0-73CE44F77F3DQ33926397-256C70FB-D68D-41BB-B006-156112F4086CQ34071095-2512A403-A7FC-4FCE-A88B-CBE60B034A82Q34368970-661D6A0D-E9B5-4488-93E4-C38923BA1DBBQ34484520-63CAAC73-B406-4AC9-BAA9-FFE0304BF324Q34484708-EAB206B0-573F-4B0E-9DF6-BFBE51EA763FQ34515561-E8B70F01-C1AD-4922-BAB1-1FE767C2868CQ34520856-5FA1A83F-1401-45D0-A00B-26F0C650215AQ34820753-0675C8D2-BB72-43ED-8560-A099116CBD88Q34873879-E0D0B432-6A7E-4702-8403-B2EA39E5ACD9Q35031724-8F6D6F85-5ABF-4DF2-9814-DEC411087D23Q35046906-C73CF5BF-03B8-4933-8246-DE96E12A813AQ35107521-0FE9E91E-9F63-498A-835B-47A4AF25BEE0Q35358229-2BB935BD-28A6-4859-8455-991C42DCE65EQ35594507-802C7EFD-D35E-4E58-B698-8A06AB0DCE37Q35598088-44F47604-1927-45EE-9FB0-2F5E7425F91AQ35610026-5BBED689-E2F2-403E-ACC6-41DB02D63A0DQ35697884-28FA60CA-398C-4DCB-A638-E14654DEBD97Q35706871-736C6B6D-4DDE-4577-9B88-14D40BB11E22
P2860
Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Contribution of cerebrovascula ...... zheimer's Coordinating Centre.
@en
Contribution of cerebrovascula ...... zheimer's Coordinating Centre.
@nl
type
label
Contribution of cerebrovascula ...... zheimer's Coordinating Centre.
@en
Contribution of cerebrovascula ...... zheimer's Coordinating Centre.
@nl
prefLabel
Contribution of cerebrovascula ...... zheimer's Coordinating Centre.
@en
Contribution of cerebrovascula ...... zheimer's Coordinating Centre.
@nl
P2093
P2860
P50
P921
P356
P1433
P1476
Contribution of cerebrovascula ...... zheimer's Coordinating Centre.
@en
P2093
Johannes Brettschneider
Kevin Raible
Sarah E Monsell
Sharon X Xie
P2860
P304
P356
10.1093/BRAIN/AWT188
P407
P577
2013-07-10T00:00:00Z